Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 8,062,000 | 2,158,000 | 31,407,000 | 22,025,000 |
| Depreciation Amortization | N/A | 7,013,000 | 6,290,000 | 5,064,000 | 5,191,000 |
| Income taxes - deferred | N/A | -2,102,000 | -3,442,000 | -3,764,000 | -4,636,000 |
| Accounts receivable | N/A | -109,000 | 347,000 | 261,000 | -3,811,000 |
| Other Working Capital | N/A | -3,066,000 | -2,172,000 | -5,639,000 | 12,804,000 |
| Other Operating Activity | 0 | 2,946,000 | 5,519,000 | 1,938,000 | 1,007,000 |
| Operating Cash Flow | $N/A | $12,744,000 | $8,700,000 | $29,267,000 | $32,580,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -2,869,000 | 13,464,000 | 7,954,000 | -19,098,000 |
| PPE Investments | N/A | -2,909,000 | -3,907,000 | -3,236,000 | -2,711,000 |
| Net Acquisitions | N/A | N/A | -43,430,000 | -22,997,000 | N/A |
| Purchase Of Investment | N/A | -180,000 | -204,000 | -1,913,000 | -1,068,000 |
| Sale Of Investment | N/A | 8,610,000 | 1,979,000 | 641,000 | 649,000 |
| Other Investing Activity | 0 | 0 | -180,000 | 3,768,000 | -318,000 |
| Investing Cash Flow | $N/A | $2,652,000 | $-32,278,000 | $-15,783,000 | $-22,546,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 6,317,000 | 7,686,000 | 3,669,000 | -96,000 |
| Debt Issued | N/A | 0 | 30,831,000 | 0 | 997,000 |
| Debt Repayment | N/A | -2,250,000 | -2,569,000 | -3,298,000 | -2,004,000 |
| Common Stock Repurchased | N/A | 0 | 0 | -2,000,000 | 0 |
| Dividend Paid | N/A | -9,512,000 | -9,247,000 | -8,983,000 | -8,729,000 |
| Other Financing Activity | 0 | -11,695,000 | -635,000 | -4,222,000 | 16,000 |
| Financing Cash Flow | $N/A | $-17,140,000 | $26,066,000 | $-14,834,000 | $-9,816,000 |
| Exchange Rate Effect | N/A | -66,000 | -40,000 | -165,000 | -59,000 |
| Beginning Cash Position | N/A | 2,917,000 | 468,000 | 1,983,000 | 1,825,000 |
| End Cash Position | N/A | 1,107,000 | 2,917,000 | 468,000 | 1,983,000 |
| Net Cash Flow | $N/A | $-1,810,000 | $2,448,000 | $-1,515,000 | $159,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 12,744,000 | 8,700,000 | 29,267,000 | 32,580,000 |
| Capital Expenditure | N/A | -2,909,000 | -3,907,000 | -3,236,000 | -2,711,000 |
| Free Cash Flow | 0 | 9,835,000 | 4,793,000 | 26,031,000 | 29,869,000 |